Anti TNF-α therapy in patients with relapsed and refractory Langerhans cell histiocytosis: a phase II study.Published in:Pediatric Hematology & Oncology, 2018, v. 35, n. 5/6, p. 362, doi. 10.1080/08880018.2018.1539149By:Flores Legarreta, Alejandra;Eckstein, Olive;Burke, Thomas M.;McClain, Kenneth L.Publication type:Article
RB1 alteration and poor prognosis in women with high-grade neuroendocrine carcinoma of the uterine cervix: a NeCTuR study.Published in:Journal of Gynecologic Oncology, 2023, v. 34, n. 4, p. 1, doi. 10.3802/jgo.2023.34.e50By:Legarreta, Alejandra Flores;Salvo, Gloria;Gonzales, Naomi R.;Chisholm, Gary;Hillman, R. Tyler;Frumovitz, MichaelPublication type:Article